KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,389,563 | +88.3% | 171,911 | +211.4% | 0.00% | 0.0% |
| Q2 2023 | $1,269,071 | +101021.2% | 55,201 | +9.7% | 0.00% | 0.0% |
| Q4 2022 | $1,255 | -99.9% | 50,300 | -54.1% | 0.00% | -50.0% |
| Q3 2022 | $2,388,000 | -19.4% | 109,685 | +56.7% | 0.00% | 0.0% |
| Q1 2022 | $2,962,000 | -40.3% | 70,000 | -45.2% | 0.00% | -50.0% |
| Q1 2021 | $4,963,000 | +860.0% | 127,727 | +697.9% | 0.00% | +300.0% |
| Q3 2020 | $517,000 | – | 16,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |